Capital International Investors lessened its stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 62.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,030,219 shares of the company's stock after selling 11,603,452 shares during the period. Capital International Investors owned about 0.52% of Keurig Dr Pepper worth $225,811,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. New Age Alpha Advisors LLC raised its position in Keurig Dr Pepper by 82.8% in the fourth quarter. New Age Alpha Advisors LLC now owns 859 shares of the company's stock worth $28,000 after purchasing an additional 389 shares in the last quarter. Whipplewood Advisors LLC bought a new position in shares of Keurig Dr Pepper during the fourth quarter valued at $37,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of Keurig Dr Pepper during the fourth quarter valued at $42,000. Brooklyn Investment Group boosted its stake in shares of Keurig Dr Pepper by 34.0% in the 4th quarter. Brooklyn Investment Group now owns 2,184 shares of the company's stock valued at $70,000 after purchasing an additional 554 shares in the last quarter. Finally, R Squared Ltd acquired a new stake in shares of Keurig Dr Pepper during the 4th quarter worth about $70,000. 93.99% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. Barclays set a $39.00 price objective on shares of Keurig Dr Pepper in a report on Thursday, February 27th. UBS Group boosted their price objective on Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. Piper Sandler upgraded shares of Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $35.00 to $40.00 in a research report on Wednesday, April 9th. TD Cowen dropped their target price on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a "hold" rating for the company in a research note on Wednesday, January 8th. Finally, JPMorgan Chase & Co. raised their price target on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Keurig Dr Pepper currently has a consensus rating of "Moderate Buy" and a consensus price target of $39.21.
View Our Latest Analysis on Keurig Dr Pepper
Insider Transactions at Keurig Dr Pepper
In other news, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the company's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $32.65, for a total transaction of $2,740,967,500.00. Following the completion of the transaction, the insider now directly owns 134,113,479 shares of the company's stock, valued at $4,378,805,089.35. This represents a 38.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Angela A. Stephens sold 7,350 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $34.17, for a total value of $251,149.50. Following the transaction, the vice president now directly owns 74,587 shares of the company's stock, valued at approximately $2,548,637.79. This trade represents a 8.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 84,421,350 shares of company stock valued at $2,757,137,010 over the last quarter. Corporate insiders own 1.00% of the company's stock.
Keurig Dr Pepper Trading Down 2.1 %
NASDAQ:KDP traded down $0.73 during trading hours on Thursday, hitting $34.46. The stock had a trading volume of 15,723,550 shares, compared to its average volume of 10,047,992. The business's 50 day moving average is $34.03 and its 200-day moving average is $33.25. The company has a market cap of $46.75 billion, a price-to-earnings ratio of 20.88, a P/E/G ratio of 2.42 and a beta of 0.54. Keurig Dr Pepper Inc. has a one year low of $30.12 and a one year high of $38.28. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.04. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The company had revenue of $3.64 billion for the quarter, compared to analyst estimates of $3.57 billion. Sell-side analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 EPS for the current fiscal year.
Keurig Dr Pepper Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 2.67%. The ex-dividend date of this dividend was Friday, March 28th. Keurig Dr Pepper's dividend payout ratio is 87.62%.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.